These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28323120)

  • 1. How to eliminate HCV infection by antiviral treatment.
    Martin NK; Vickerman P; Hickman M
    J Hepatol; 2017 Jul; 67(1):5-6. PubMed ID: 28323120
    [No Abstract]   [Full Text] [Related]  

  • 2. Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030.
    Dore GJ; Grebely J
    J Hepatol; 2017 Aug; 67(2):419-420. PubMed ID: 28411042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current management of hepatitis C].
    Lange CM
    Med Monatsschr Pharm; 2015 Sep; 38(9):337-44; quiz 345-6. PubMed ID: 26731851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selection of direct-acting antiviral agents for chronic hepatitis C infection].
    He YJ; Liu ZH; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):169-172. PubMed ID: 29804388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New hepatitis C antiviral treatments eliminate the virus.
    Doyle JS; Thompson AJ; Higgs P; Stoove M; Dietze PM; Hellard ME
    Lancet; 2017 Jul; 390(10092):358-359. PubMed ID: 28689663
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic HCV infection: An internist's opinion (Part 2)].
    Zubkin ML; Chervinko VI; Ovchinnikov YV; Kryukov EV; Kotenko ON
    Ter Arkh; 2016; 88(11):138-148. PubMed ID: 28635834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012].
    Sarrazin C; Zimmermann T; Berg T; Neumann UP; Schirmacher P; Schmidt H; Spengler U; Timm J; Wedemeyer H; Wirth S; Zeuzem S; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Z Gastroenterol; 2018 Jul; 56(7):756-838. PubMed ID: 29945279
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic viral hepatitis C with direct acting antiviral agent: review].
    Malov VA; Ubeeva EA; Ubeeva IP; Nikolaev SM; Umbetova KT
    Ter Arkh; 2019 Nov; 91(11):86-89. PubMed ID: 32598617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective and how durable is DAA-therapy in HCV-infected drug users?
    Ingiliz P; Tacke F
    Liver Int; 2019 Dec; 39(12):2238-2239. PubMed ID: 31777171
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
    Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
    Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis: Drug-drug interactions in HCV treatment--the good, the bad and the ugly.
    Langness JA; Everson GT
    Nat Rev Gastroenterol Hepatol; 2016 Apr; 13(4):194-5. PubMed ID: 26882885
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?
    Asselah T; Marcellin P; Schinazi RF
    Liver Int; 2018 Feb; 38 Suppl 1(Suppl 1):7-13. PubMed ID: 29427484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Last crusade against HCV: Direct-acting antiviral treatment for marginalized populations.
    Fujii H; Enomoto M; Murakami Y; Hagihara A; Kawada N; Saito S
    J Viral Hepat; 2019 Dec; 26(12):1501. PubMed ID: 31411788
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging antiviral drugs for hepatitis C virus.
    Enomoto M; Tamori A; Kawada N
    Rev Recent Clin Trials; 2009 Sep; 4(3):179-84. PubMed ID: 20028330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of chronic hepatitis C. Practical recommendations and new developments].
    Niederau C
    Med Klin (Munich); 2001 Oct; 96(10):599-607. PubMed ID: 11715332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral therapy of chronic hepatitis C: 30 years success story].
    Abdurakhmanov DT; Rozina TP; Nikulkina EN; Burnevich EZ; Tanashuk EL; Severov MV; Filatova AL; Milovanova SY; Karpov VV; Moiseev SV
    Ter Arkh; 2019 Nov; 91(11):110-115. PubMed ID: 32598621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: chronic hepatitis C genotype 3 infection - still a hurdle toward a direct-acting anti-viral-induced HCV cure?
    Bruno G; Milella M; Angarano G; Saracino A
    Aliment Pharmacol Ther; 2017 May; 45(10):1376-1377. PubMed ID: 28417495
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
    Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
    J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
    Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.